Genetic polymorphisms in PNPLA3, TM6SF2, GCKR, and MBOAT7, may also contribute to the occurrence of NAFLD in non-obese [24–26]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.